Xanthine Oxidase Inhibitors / UricosuricsSemi-mechanistic PK/PDRheumatology

PKPD model for lesinurad (Zurampic)

Indication: Hyperuricemia associated with gout (combination with xanthine oxidase inhibitors)

Interactive semi-mechanistic simulator of uric acid dynamics in hyperuricemia. Explore effects of xanthine oxidase inhibitors (allopurinol, febuxostat) and uricosuric agents (lesinurad) on serum uric acid based on patient GFR and fractional excretion. Based on Aksenov et al. 2018.

Drug Overview

Clinical Context

Drug Class
Xanthine Oxidase Inhibitors / Uricosurics
Therapeutic Area
Rheumatology
Indication
Hyperuricemia associated with gout (combination with xanthine oxidase inhibitors)

Model Information

Model Type
Semi-mechanistic PK/PD

This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.

About This Simulator

This interactive pharmacokinetic simulator for PKPD model for lesinurad (Zurampic) allows you to explore concentration-time profiles under different dosing scenarios. The underlying Semi-mechanistic PK/PD model characterizes the pharmacokinetics of this xanthine oxidase inhibitors / uricosurics.

Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration). The pharmacodynamic component links drug exposure to therapeutic or safety endpoints.

Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.

Frequently Asked Questions

What is the PKPD model for lesinurad (Zurampic) PK simulator?

This is a free, interactive pharmacokinetic simulator for PKPD model for lesinurad (Zurampic) used in Hyperuricemia associated with gout (combination with xanthine oxidase inhibitors). It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.

What drug class does PKPD model for lesinurad (Zurampic) belong to?

PKPD model for lesinurad (Zurampic) is classified as a Xanthine Oxidase Inhibitors / Uricosurics. It is used in the Rheumatology therapeutic area.

What type of PK model is used?

This simulator uses a Semi-mechanistic PK/PD model. PK/PD models link drug concentrations to pharmacological effects, allowing exploration of exposure-response relationships.

Is this simulator free to use?

Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.

Can I use this for clinical dosing decisions?

No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.

Ready to Simulate?

Launch the PKPD model for lesinurad (Zurampic) simulator to explore dosing scenarios and pharmacokinetic profiles interactively.

🚀 Launch Simulator

Comments

0/2000
Loading comments...

⚠️ Disclaimer

This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.

Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community